CAS 1191044-47-9

Butanedioic acid, compd. with N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]acetamide (1:)

Description:

Butanedioic acid, compd. with N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]acetamide (1:) is a complex organic compound characterized by its unique structural features, which include a butanedioic acid moiety and a bicyclic amide structure. The presence of a thiazole-pyridine derivative suggests potential biological activity, possibly as a pharmaceutical agent. The compound's molecular structure indicates it may exhibit specific interactions with biological targets, making it of interest in medicinal chemistry. Its solubility, stability, and reactivity would depend on the functional groups present and the overall molecular architecture. Additionally, the compound's CAS number, 1191044-47-9, allows for precise identification in chemical databases, facilitating research and development efforts. Overall, this compound exemplifies the complexity often found in drug design, where multiple functional groups and structural motifs are combined to achieve desired therapeutic effects.

Synonyms:

• Butanedioic acid, compd. with N-[(3-endo)-8-[[4-(thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]oct-3-yl]acetamide (1:)

JNJ-40929837 succinate

CAS: 1191044-47-9

JNJ-40929837 succinate is a selective, orally active inhibitor of LTA 4 H (leukotriene A 4 hydrolase). This compound effectively inhibits aminopeptidase activity, leading to the accumulation of Pro-Gly-Pro in serum, and can be utilized in asthma research [1].

Formula: C₂₂H₂₄N₄O₂S·xC₄H₆O₄

Color and Shape: Solid

Ref: TM-T86771